Yunlei Xianyu

Sir Run Run Shaw Hospital

Papers

1

Total Citations

22

H-Index

1

About

Yunlei Xianyu is a pioneering researcher at the intersection of nanobiotechnology, microalgae engineering, and gastrointestinal therapeutics. Their most notable contribution is the development of a "Microalgae-Probiotic-Nanozyme Robot," a groundbreaking biohybrid system that integrates living microalgae, probiotics, and nanozymes to combat inflammatory bowel disease (IBD). This innovative platform simultaneously alleviates persistent intestinal inflammation, repairs the damaged gut barrier, and restores microbiota dysbiosis—addressing the oxidative stress and therapeutic limitations of conventional treatments. The work, published in 2025, has already garnered 22 citations, reflecting its rapid impact on the field. Xianyu’s research uniquely bridges materials science and microbiology, offering a living, self-propelling therapeutic strategy that could transform chronic gastrointestinal disorder management. By engineering these "robots" to navigate the gut environment and deliver multi-modal therapy, Xianyu has opened new avenues for precision medicine in inflammatory conditions. Their contributions are particularly significant for students and researchers interested in biohybrid systems, nanomedicine, and the microbiome, showcasing how interdisciplinary design can solve complex biological challenges.

Research Focus

Key Achievements

1
H-Index
1
Papers
22
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
A Microalgae‐Probiotic‐Nanozyme Robot for Alleviating Intestinal Inflammation and Microbiota Dysbiosis
22 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Sir Run Run Shaw Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago